FIELD: medicine.
SUBSTANCE: invention refers to new compounds exhibiting antiproliferative activity of formula (1) where W means N or C-R2; X means -NH-; Y means CH; Z means halogen, -NO2, C2-C3alkynyl-, halogen-C1-C3alkyl- and -C(=O)-C1-C3alkyl, A means a group of formula (i), (ii) or (iii) Q1 means phenyl; B1, B2, B3 and B4 independently mean C-RgRh, N-Ri or O; R1 means hydrogen; R2 means a residue specified from the group including hydrogen, halogen and -OR4; Ra, Rb, Rc, Rd, Re and Rf independently mean hydrogen; Rg and Rh independently mean a residue specified from the group including hydrogen, =O, -OR4 and -NR4C(=O)R5; or mean optionally a residue monosubstituted or twice-substituted with equal or different substitutes and specified from the group including C1-C6alkyl and phenyl, the substitute/substitutes is/are specified from the group including R8/, -OR4, -C(=O)R4, -C(=O)OR4 and -C(=O)NR4R5 where R8/ and other values of radicals are specified in the patent claim, optionally in the form of their pharmacologically noncontaminating acid addition salts. The invention also concerns a pharmaceutical composition.
EFFECT: new compounds have effective biological properties.
8 cl, 6 dwg, 1086 ex
Title | Year | Author | Number |
---|---|---|---|
INHIBITIN CDK-KINASES PYRIMIDINES AND THEIR APPLICATION AS MEDICINES | 2002 |
|
RU2330024C2 |
N-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITOR | 2003 |
|
RU2307831C9 |
THIAZOLYL DIHYDROQUINAZOLINES | 2007 |
|
RU2430923C2 |
2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
THERAPEUTICALLY ACTIVE TRIAZOLES AND USE THEREOF | 2007 |
|
RU2469042C2 |
PYRIMIDINE COMPOUND (VARIANTS) AND PHARMACEUTICAL COMPOSITION SHOWING AFFINITY TO DOPAMINE D-RECEPTORS | 1995 |
|
RU2172736C2 |
C-MET ANTAGONIST AND AMINOHETEROARYL COMBINATION FOR TREATING CANCER | 2009 |
|
RU2526171C2 |
SUBSTITUTED DERIVATIVES OF CYCLOHEXAN-1,4-DIAMINE, METHOD FOR THEIR PREPARING AND DRUG | 2002 |
|
RU2321579C2 |
METHOD OF SYNTHESIS OF DERIVATIVES OF SUBSTITUTED 2-NITROGUANIDINE AND METHODS OF SYNTHESIS OF IN- TERMEDIATE COMPOUNDS | 1998 |
|
RU2202544C2 |
N3-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS | 2003 |
|
RU2300528C2 |
Authors
Dates
2010-11-27—Published
2005-08-18—Filed